4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031378
EVP & Chief Commercial Officer sold 700 shares at an average $113.67 ($79,572)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-06 | Sale : show line 1 in the form | −307 | $113.68 | $34,900 | 27,110 | D |
| 2021-05-07 | Sale : show line 2 in the form | −393 | $113.67 | $44,672 | 26,717 | D |
| Open-market sales · 700 sh · avg $113.67 · $79,572 | ||||||
Loading xslF345X03/doc4.xml…